The Hidden Costs of Fertility by Cato, Rev. Phillip C., Ph.D.
Journal of Civil Rights and Economic Development 
Volume 20 
Issue 1 Volume 20, Fall 2005, Issue 1 Article 4 
September 2005 
The Hidden Costs of Fertility 
Rev. Phillip C. Cato Ph.D. 
Follow this and additional works at: https://scholarship.law.stjohns.edu/jcred 
Recommended Citation 
Cato, Rev. Phillip C. Ph.D. (2005) "The Hidden Costs of Fertility," Journal of Civil Rights and Economic 
Development: Vol. 20 : Iss. 1 , Article 4. 
Available at: https://scholarship.law.stjohns.edu/jcred/vol20/iss1/4 
This Symposium is brought to you for free and open access by the Journals at St. John's Law Scholarship 
Repository. It has been accepted for inclusion in Journal of Civil Rights and Economic Development by an 
authorized editor of St. John's Law Scholarship Repository. For more information, please contact 
selbyc@stjohns.edu. 
THE HIDDEN COSTS OF FERTILITY
REV. PHILLIP C. CATO, PH.D.*
About 10% of all couples in the United States experience
infertility.1 Apparently there is very widespread public support
for the capabilities of assisted reproductive technology,
specifically in vitro fertilization, to address this problem. Behind
this support, which cuts across most ideological lines, is the belief
that a couple has a right to have a baby, to be parents, and/or to
have biological successors. The immediate goal is to produce
healthy children; the means are many and varied, and the
consequences include children - 177,000 since 19812 - but much
more than children. There are many undesirable, though not
unforeseeable, consequences which society and the law should
address. Assisted reproductive technology is at once helpful and
harmful. The potential harms, and they are myriad, require a
legal and legislative response.
Necessary to this topic is a discussion of "assisted reproductive
technology." What is assisted reproductive technology? Most of
us will associate it with in vitro fertilization. That means
fertilizing an egg with sperm in a laboratory dish (in vitro - in
glass, rather than in vivo - in the body) and then transferring the
fertilized egg into the uterus of the female member of the
infertile couple, where hopefully it will implant and become first
These remarks are an actual transcript of the author's comments at the St. John's
Journal of Legal Commentary Symposium on Feb. 25, 2005.
1 See American Society for Reproductive Medicine, Quick Facts About Infertility,
http://www.asrm.org/Patients/faqs.html (last visited Sept. 1, 2005) (stating that infertility
affects over six million women and their partners, representing about 10% of America's
reproductive age population).
2 See American Society for Reproductive Medicine, Frequently Asked Questions About
Infertility, http://www.asrm.org/Patients/faqs.html#Q7: (last visited Sept. 1, 2005)
(stating that in vitro fertilization was first introduced in America in 1981 and, from 1985
to 2000, more than 139,000 babies have been born via this technology).
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a fetus and then a healthy baby. 3 That sounds pretty
straightforward and we are all glad that couples who cannot, for
a variety of reasons, conceive through normal sexual intercourse
have a workable alternative. That understanding, though very
widespread, falls a bit short of the reality. Because the causes of
infertility are many, there are many remedies, which are growing
in number all the time, largely out of public view.
Let me address a few of the variations. We will do this as we
make our way through the processes of assisted reproductive
procedures, with which some of you may not be familiar. The
husband or male partner may contribute the sperm, if his sperm
are viable and accessible, by interrupted intercourse or by means
of stimulated ejaculation. 4 In some men, that is impossible and
the sperm must be collected surgically. There are even rare
instances when the latter is performed shortly after death. When
surgical means are used, it may also be that spermatids, which
are immature sperm, are collected for round spermatid nuclear
injection (ROSNI).5 This is necessary when mature sperm are not
developing. This procedure is not often used because of
unresolved genetic concerns.
There may be no viable sperm available from the male for a
variety of reasons. In these cases, donor sperm may be used.
Medical students are a primary source; though, important for our
concerns today, the donor may be a family member or a known
acquaintance. Usually these donors are anonymous and
surrounded by confidentiality and privacy provisions - provisions
that have willy-nilly been uncritically extended to the entire
assisted reproductive enterprise. Self-evidently, this anonymity
prevents the conceived child from access to their genetic history
and biological parentage. Where the donor is a family member or
a known acquaintance, there is no anonymity but there is a
3 See id. (describing in vitro fertilization as one assisted reproduction process,
wherein sperm and egg are joined in a Petri dish, fertilization occurs, and a resulting
embryo is later transferred in utero for natural development).
4 See American Society for Reproductive Medicine, Husband Insemination: A Guide
For Patients (1995), http://www.asrm.org/Patients/patientbooklets/husbandinsem.pdf
(explaining various methods for collecting semen, including masturbation and intercourse
into a special doctor-provided condom).
5 See Robert Jansen, M.D., Overcoming Infertility Dictionary, http://www.jansen.com.
au/DictionaryPR.html (last visited Sept. 1, 2005) (defining "round spermatid nuclear
injection" as the "experimental form of testicular sperm extraction (TESE) followed by
intracytoplasmic sperm insertion (ICSI) in which the nucleus of a round (very immature)
spermatid is isolated for injection into the egg (or secondary oocyte)").
THE HIDDEN COSTS OF FERTILITY
complex confusion of kinship relationships. 6 There should be
limitations to the number of times one person can be a donor;
this is tied to the population of the area in which the donations
are made because of the risk of genetically related persons
meeting and conceiving. The professional associations make the
necessity of this limitation very clear, but there is no
enforcement mechanism.
The ovum, the egg, the oocyte is retrieved from the female
partner, wife or other. 7 Since conception is considered to be
chancy, it is desirable to have multiple eggs available. Since,
normally, only one egg is produced in each cycle, the woman
must be stimulated with hormone injections (gonadotropins) to
hyperstimulate the ovaries into producing multiple eggs at once. 8
The eggs are retrieved from the stimulated follicles using
ultrasound and a special needle, either transvaginally or through
the abdomen. There are obvious discomfort and safety issues
involved in this procedure. In some instances, a woman may be
unable to produce ova. The alternative is an oocyte donor; these
are widely recruited through newspaper ads offering $ 5,000 or
considerably more. 9 Privately-recruited donors may be offered
very much more. Such advertisements frequently appear in
college newspapers, especially at the beginning of the academic
year.O If you are a young woman worried about how you are
going to manage the costs of your education, or have money for
living expenses after you pay your tuition, these offers are
powerful incentives to become a donor. Such incentives may
skewer the consent process and shortcut a sober assessment of
6 See The Ethics Committee of the American Society for Reproductive Medicine, 2004
Compendium of ASRM Practice Committee and Ethics Reports, 82 FERTILITY &
STERILITY, Supp. 1, Tab. 1 (2004) (describing potential confusion regarding familial
relationships where donor is either family member or known acquaintance).
7 See American Society for Reproductive Medicine, Assisted Reproductive
Technologies: A Guide for Patients (2003), http://www.asrm.org/Patients/patientbooklets
/ART.pdf, 6 (describing egg retrieval through transvaginal ultrasound aspiration).
8 See id. at 4 (explaining that fertility drugs stimulate ovaries to produce multiple
eggs, instead of the typical single egg produced every month).
9 See The Ethics Committee of the American Society for Reproductive Medicine,
Financial Incentives in Recruitment of Oocyte Donors, 74 FERTILITY & STERILITY 2, 216
(2000), available at http://www.asrm.org/Media/Ethics/financial incentives.pdf (describing
advertisements which offered as much as $50,000 for a single oocyte donation, though
payment was not verified).
10 See id. (stating that infertile couples, programs, and independent agencies often
recruit women for oocyte donation through advertisements, which are often placed in
college notices or local newspapers).
2005]
48 ST JOHN'S JOURNAL OF LEGAL COMMENTARY [Vol. 20:1
the potential harms during the procedure and in later
reproductive functioning. Furthermore, as with the sperm donor,
the female egg recipient may have a family member as a donor.
This brings about very convoluted kinship relationships, and may
be a source of considerable emotional distress.
Clearly, there are ethical concerns about paying for human
tissue, which is generally forbidden. The clinics say that they are
not paying for the oocytes, but rather compensating the donors
for their time and inconvenience. While this time and
inconvenience far exceeds that experienced by the sperm donor,
the size of the reward makes the rationale for payment suspect.
The claims of the clinics regarding the rationale for these
payments stretch the limits of credulity.
Hyperstimulation of the ovaries is a risky business and may
lead to ovarian hyperstimulation syndrome (OHSS).ll This can
be a serious condition requiring hospitalization, and the most
serious manifestations can be life threatening.12 Repeated
hyperstimulation increases the risk, since mild OHSS is not an
uncommon occurrence. Again, we need to be concerned about the
consent process, especially for the paid donors.
Whether sperm is donated, or eggs are donated, or both, the
resulting child is denied access to their genetic heritage. The
wall of confidentiality and privacy, which has a solid justification,
also screens the entire assisted reproductive process. It is far
from clear that this should be the case.
Clinics screen donors. To be more accurate, they say that they
should screen donors. In addition, their professional
associations, including the American Society for Reproductive
Medicine (ASRM)13 and the Society for Assisted Reproductive
11 See Lee A. Fox, M.D. & Mary Frates, M.D., Ovarian Hyperstimulation Syndrome
(1996), http://brighamrad.harvard.edu/Casesbwhlhcache/205/full.html (explaining
ovarian hyperstimulation syndrome, one potential risk of ovarian hyperstimulation).
12 See National Guidelines Clearinghouse National Guidelines Clearinghouse,
Ovarian Hyperstimulation Syndrome (2003), http://www.guideline.gov/summary/
summary.aspX?viewid+1&doc-id=4845 (discussing that, while hospitalization due to
ovarian hyperstimulation syndrome is uncommon, the syndrome itself is not rare).
13 See American Society for Reproductive Medicine, Mission Statement (2000),
available at http://www.asrm/mission.org.html (stating nature and goal of said society is
to be a "multidisciplinary" organization seeking to advance the "art, science and practice
of reproductive medicine").
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Technology (SART), 14 urge them to do so, but compliance is
voluntary and the societies' guidelines, though thorough, are
hortatory. The only sanction is expulsion from the association.
In January of 2005, the ASRM published an article in their
journal, FERTILITY AND STERILITY, entitled Screening Practices
and Beliefs of Assisted Reproductive Technology Programs,15
which is "must" reading. This article received a lot of notoriety in
the press. The Deseret Morning News titled their AP account
"Fertility Clinics Lack Policies About Ethics."16 Another opined
that these clinics were likely to screen your bank account and
little more. 17 Absent legal or legislative guidance, it is not at all
obvious to what degree prospective parents can be screened and
on what basis. If all these procedures are defined as normal
medical care, how can physicians refuse treatment to those who
present the problem? But there is the persistent problem that
these procedures are very expensive and only those who can
afford them have access.
Technology is key here. Once the gametes are retrieved, they
are put in a culture of nutrients (amino acids, glucose,
antibiotics, sodium, chloride, potassium) to grow to the morula or
blastocyst stage prior to being transferred.18 Not all these
cultures are the same, and they have an influence on the
imprinting of the genes; namely, which genes are silent and
which are expressed. It is an open question whether these
cultures and their effect on imprinting are responsible for, say,
14 See Society for Assisted Reproductive Technology, Mission Statement, available at
http://sart.org/hometext.html (last visited Sept. 18, 2005) (advancing standards for
practice of assisted reproductive technology to benefit society).
15 American Society for Reproductive Medicine, Screening Practices and Beliefs of
Assisted Reproductive Technology Programs, 83 FERTILITY & STERILITY 1 (2000),
available at www.asrm.org (discussing implications of screening practices regarding
assisted reproductive technologies).
16 See Marilynn Marchione, Fertility Clinics Lack Policies About Ethics, DESERET
MORNING NEWS, Jan. 19, 2005, at A02 (discussing ethics of fertility clinics).
17 See Stacey A. Huse, The Need for Regulation in the Fertility Industry, 35 U. OF
LOUISVILLE J. OF FAM. L. 555, 558 (1996/97) (noting possibility of fraud or other crimes
occurring in fertility industry due to amount of money the industry accrues).
18 See Mary Lyndon Shanley, Collaboration and Commodification in Assisted
Procreation: Reflections on an Open Market and Anonymous Donation in Human Sperm
and Eggs, 36 LAW & SOC'¥ REV. 257, 264-65 (2002) (discussing how extracted eggs, placed
in culture dishes with sperm and which seem to be fertilized, are placed in an incubator
for twenty-four hours, after which time, fertilized eggs would have divided into two, four,
or eight cells).
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Beckwith syndrome, an abnormal skeletal development. 19 The
fact that we do not know what the various cultures are doing is
worrying and is a safety factor. In and of itself, this impacts the
consent process.
It is not always the case that the egg and sperm are mixed in
the culture where they may join the way they usually do. This is
often not left to chance. The retrieved sperm are actually
inserted into the egg using a micropipette. This process, called
introcytoplasmic sperm injection (ICSI),20 involves cutting
through the zona pellucida matrix and the oolema, the coverings
of the egg, "to deliver the male genome directly into the
ooplasm." 21 Several studies have raised questions about the long-
term affects, including "a possible increased risk of sex
chromosomal abnormalities in ICSI pregnancies." 22
Prior to transfer to the uterus, some couples have clinics do
preimplantation genetic diagnosis (PGD).23 One or two
blastomeres are removed at about the eight cell stage, at day
three after fertilization, and the genomic status is assessed.24
The ostensible purpose is to detect genetic defects, but this
procedure may also used for sex selection, and who knows for
what else down the road? The procedure is costly, approximately
$2,500 per cycle, 25 and the centers that provide it do not report
19 See John A. Robertson, Procreative Liberty and Harm to Offspring in Assisted
Reproduction, 30 AM. J. L. AND MED. 7, 9 (2004) (stating children born from in vitro
fertilization are at a higher risk for certain rare birth defects and lower birth weight);
Robin Fretwell Wilson, Uncovering the Rationale for Requiring Infertility in Surrogacy
Arrangements, 29 AM. J. L. AND MED. 337, 345 (2003) (noting study that reported children
born from in vitro fertilization are six times more likely to develop Beckwith Syndrome).
20 See Gerald Schatten et al., Cell and Molecular Biological Challenges of ICSI: ART
Before Science?, 26 J.L. MED. & ETHICS 29, 31-32 (1998) (discussing how, in ICSI,
biologists select successful sperm and physically injects said sperm into an egg via
microinjection needle).
21 Does Intracytoplasmic Sperm Injection (ICSI) Carry Inherent Genetic Risks? 82
FERTILITY & STERILITY 151, 151 (2004 & Supp. I).
22 Id.
23 See Richard J. Tasca & Michael E. McClure, The Emerging Technology and
Application of Preimplantation Genetic Diagnosis, 26 J. L. MED. AND ETHICS 7, 8 (1998)
(discussing preimplantation genetic diagnosis as one way to prevent certain genetic birth
defects and diseases from passing to future generations; furthermore, potential parents
can utilize such diagnoses prior to pregnancy to see if their fetus has a genetic disease or
birth defect).
24 See id. at 7 (describing said procedure as the removal of one or more cells at
cleavage stage, and then performing genetic analysis).
25 See Preimplantation Genetic Diagnosis, 82 FERTILITY & STERILITY, 120, 120-22
(2004 & Supp. 1) (noting approximate cost of PGD being $2500 per cycle); see also Jeffrey
R. Botkin, Ethical Issues and Practical Problems in Preimplantation Genetic Diagnosis, 26
J.L. MED. AND ETHICS 17, 18 (1998) (noting though PGD involves a high cost, couples have
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out, so there is no way to assess problems related to this
diagnostic procedure. Again, the lack of regulation leaves this
practice cloaked in secrecy. 26
The next step in this assisted process is to transfer the morula
or blastocyst stage fertilized egg to the uterus, or occasionally to
the fallopian tubes. 27 But this may not be possible because the
woman has no uterus, because of a hysterectomy, or has a
diseased uterus, or some other disqualifying condition. It is then
necessary to have a surrogate mother to carry the conceptus to
term. This raises another raft of legal, ethical, and emotional
issues. Surrogacy is arranged contractually with the intention
that the surrogate will return the baby to the couple that
contracted with her. But "no court has ever forced any person to
fulfill the terms of a surrogate-mother contract by requiring that
the parties be bound by the contractual terms regardless of their
current wishes ... ."28 So the surrogate who chooses to keep the
baby has a strong case.
We do not have time to explore it, but you can have donor
sperm, a donor egg, and a surrogate gestational mother. It can
happen, in the midst of all this, to have the couple that planned
and contracted for the baby to get divorced during the gestation
period. Annas, cited above, describes the issues in just such a
case.29 The California court ruled in Buzzanca v. Buzzanca 30 that
burden of paying because insurance companies do not cover costs for unnecessary
interventions).
26 See Preimplantation Genetic Diagnosis, supra note 25, at 120-22 (affirming that
many centers do not report PGD results, therefore limiting information tied to such
procedures).
27 See Mary Ann Davis Moriarty, Comment, Addressing In Vitro Fertilization and the
Problem of Multiple Gestations, 18 ST. Louis U. PUB. L. REV. 503, 508 (1999) (noting how,
after fertilization and embryo culture, said embryo is transferred to the woman).
28 George J. Annas, The Shadowlands - Secrets, Lies, and Assisted Reproduction, 339
NEW ENG. J. MED., 935, 935-39 (1998).
29 See id. (discussing problems that arise when couples get divorced during gestation
of a surrogate pregnancy); see also Ian McCallister, Survey: Modern Reproductive
Technology and the Law: Surrogacy Contracts in the United States and England, 20
SUFFOLK TRANSNAT'L L. REV. 303, 308-09 (1996) (discussing four possible categories that
legislative responses to surrogacy contracts fall into: prohibition, which seeks to prevent
surrogacy arrangements; facilitation, where government tries to enforce agreements made
by consenting parties; regulation, where contracts would be enforced if certain criteria
were met; and static approach, which allows courts to address questions of custody and
contract enforcement).
30 Buzzanca v. Buzzanca, 61 Cal. App. 4th 1410 (1998).
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the couple that planned and contracted were the legal parents. 31
Most important, consider the plight of the child.
In assisted reproductive procedures, multiple fertilized eggs
are transferred, and, not surprising, these can and often do result
in multiple births, far more than would naturally be occurring.
The number of twins, triplets and even greater multiples are
growing exponentially owing to alternative reproductive
technologies. 32 When there are multiple gestations and births,
problems abound. It may become necessary to reduce the
number of fetuses during gestation in order to enhance the
chances of survival of the others. Premature delivery and low
birth weight babies are common.33 These babies often require
neonatal intensive care and can have a disproportionate number
of developmental deficits. To date there have been no
longitudinal studies of alternative reproductive technology
babies, so we do not have information about long-term
developmental problems. Much of this is hidden from public
view, but the monetary and societal costs are enormous.
Not all the early embryos are transferred; only those that
implant and have a normal gestation become babies.
Implantation often does not happen and the pre-embryos which
are not transferred are cryopreserved, frozen in liquid hydrogen,
in hopes of another try. This cryopreservation is very expensive
and can last for years. The continuing cost is often a major cause
of embryo abandonment and it is still not known how long these
embryos remain viable.
If pregnancy is accomplished, especially multiple birth
pregnancy, the other embryos may not be needed. The couple
may then donate them to another infertile couple, donate them
for early embryo research or as a source for embryonic stem cells,
order that they be discarded, or abandon them, in which case
they will be discarded. The clinic has no authority to designate
31 Id. at 1421 ('The statute contemplates the establishment of lawful fatherhood in a
situation where an intended father has no biological relationship to a child who is
procreated as a result of the father's (as well as the mother's) consent to a medical
procedure.").
32 See Use of Assisted Reproductive Technology - United States, 1996 and 1998,
Centers for Disease Control (Feb. 8, 2002), available at http://www.cdc.gov/mmwr/preview
/mmwrhtmllmm5lO5a 2.htm (summarizing statistics of increased multiple births due to
ART).
33 See id. (connecting ART to increased risks for pregnancy complications, such as low
birth weight).
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their use. At the present there are in excess of four-hundred-
thousand frozen embryos in the United States.34
If those frozen embryos are donated for research, it raises the
question of patenting the products or knowledge of that research.
A January, 2005 Staff Working Paper for the President's Council
on Bioethics, entitled, Biotechnology and Public Policy:
Biotechnologies Touching the Beginnings of Human Life, takes
note that "the need for a provision instructing the United States
Patent and Trademark Office not to issue patents on claims
directed to or encompassing human embryos or fetuses at any
stage of development; and amending Title 35, United States
Code, § 271(g) ... to exclude these items from patentability."35
Assisted reproductive professional societies are quick to
designate the emerging technologies in reproductive medicine as
standard medical care, rather than concede that they are, in
some cases, human experimentation. Should any of these
technologies become designated as medical experimentation, they
would come under the scrutiny of the Office for Human Research
Protections. This office can be presumed to take an activist
posture to protect human subjects, especially in light of recent
deaths in genetic research. Federal legislation is clearly needed
to provide some regulation of this industry.36 Some issues in this
arena include product liability, conflicts of interest, tightening of
standards for institutional review boards, standards of care and
potential research fraud. A number of suggestions for pending
legislative needs may be found in the Executive Summary of the
New York Task Force on Life and the Law, revised 2001.37
As you can see, even from this summary description of assisted
reproductive technology, there are innovations at every level of
intervention and in each varying circumstance. There is no
reason to think that the innovation will stop; it is the nature of
34 See How Many Frozen Human Embryos are Available for Research?, RAND LAW
AND HEALTH (2003), available at http://www.rand.org/publications/RB/RB9038/ (declaring
that approximately "400,000 embryos have been frozen and stored since the late 1970's").
35 The President's Council on Bioethics, Biotechnology and Public Policy:
Biotechnologies Touching the Beginnings of Human Life, (Oct. 2003), available at
http://www.bioethics.gov/background/bpp_ defend-dig.html.
36 See Michelle M. Mello et al., The Rise of Litigation in Human Subjects Research,
139 ANNALS OF INTERNAL MED. 1, 40-45 (2003) (positing that such technology is becoming
haphazardly defined in legal arena).
37 See generally N.Y.S. Dept. of Health, Executive Summary of the Task Force on Life
and the Law (Oct. 2001), http://www.health.state.ny.us/nysdoh/taskfce/execsum.htm
(proposing legal, technical, and practical solutions to assisted reproductive technologies).
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science and technology to press on to new investigations and
ingenuities. In this case, it has to do not only with the processes
of human reproduction, but also the formation of human beings
and their subsequent development. Because the practices and
their results also rearrange kinship relationships, emotional ties,
genetic origins, future reproductive capacities, our valuations of
nascent human life, our sense of identity, often abuse the consent
process, expose adult participants and the resulting children to
unidentified dangers, threaten inadvertent expressions of
consanguinity, utilize new techniques and technologies without
proper human trials, and operate largely without public or
regulatory scrutiny, it is self evident that legislative remedies are
needed. It is not sufficient to wait for harms to occur and
resolution to be sought in litigation and its subsequent appeals
process.
As the President's Council on Bioethics has recently concluded,
there is a need for:
* A uniform, comprehensive, and enforceable
mechanism for data collection, monitoring, or
oversight for the biotechnologies affecting human
reproduction and for determining how the new
reproductive biotechnologies affect the well-being of
the children conceived with their aid, the egg
donors, or the gestational mothers. Such a
mechanism is also needed regarding the use and
disposition of in vitro human embryos in the context
of clinical practice and research.
* Nationally uniform laws or policies for access to
assisted reproduction.
" Regulations that address the way that novel
technologies and practices which are successful
move from the experimental context to clinical
practice with relatively little oversight or
deliberation and are used at clinicians' discretion,
with little or no external oversight, whose usage
spreads very rapidly.
* Regulation of commerce in gametes, embryos, and
assisted reproductive technology services.
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* A uniform system for public review and deliberation
regarding the larger human or social significance of
new reproductive biotechnologies.
* Regulation of preimplantation genetic diagnosis. 38
The President's Council also recommends that Congress
should,
at least for a limited time:
* Prohibit the transfer, for any purpose, of any human
embryo into the body of any member of a non-
human species.
* Prohibit the production of a hybrid human-animal
embryo by fertilization of [a] human egg by animal
sperm or of [an] animal egg by human sperm.
* Prohibit the transfer of a human embryo (produced
ex vivo) to a woman's uterus for any purpose other
than to produce a live-born child.
* Prohibit attempts to conceive a child by any means
other than the union of egg and sperm.
* Prohibit attempts to conceive a child by using
gametes obtained from a human fetus or derived
from human embryonic stem cells.
* Prohibit attempts to conceive a child by fusing
blastomeres from two or more embryos.
* Prohibit the use of human embryos in research
beyond a designated stage in their development
(between ten and fourteen days after fertilization).
38 See The President's Council on Bioethics, Reproduction and Responsibility: the
Regulation of New Biotechnologies (Mar. 2004), http://www.bioethics.gov/reports/
reproductionandresponsibility/fulldoc.html.
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* Prohibit the buying and selling of human embryos. 39
Taking these steps, or at least arguing them in legislative
bodies, will go a long way toward bringing assisted reproductive
technology under public scrutiny. Ethical practice has nothing to
fear from the light of day, and this widespread practice is already
proving too costly for the benefit gained and needs that bright
light shined upon it. We will live with the children so conceived,
and many of us will experience first-hand the unintended
consequences of what began as a compassionate response to a
widespread and often heartbreaking condition: infertility.
This audience and others like you are best positioned to create
workable remedies. I invite your careful attention to these
specific issues.
39 Id.
